Researchers develop a simple method to make immune cells better at spotting and destroying tumors
The GPNMB–RYK ligand–receptor pathway—a novel therapeutic target for MASH
Scientists reveal multiple compositions and fully open state of native NMDA receptors in the brain
Li Hongjie Honored with 2025 “Shanghai Science & Technology 35 Under 35” Nomination Award
